KeyCorp upgraded shares of Guardian Pharmacy Services (NYSE:GRDN – Free Report) to a strong-buy rating in a report released on Tuesday morning,Zacks reports.
GRDN has been the subject of several other reports. Weiss Ratings upgraded Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. Truist Financial upped their price target on Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a research report on Monday. Wall Street Zen cut shares of Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research report on Saturday. Oppenheimer increased their price target on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research note on Friday, August 7th. Finally, Bank of America increased their price target on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $45.57.
Read Our Latest Stock Analysis on GRDN
Guardian Pharmacy Services Stock Performance
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The business had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. As a group, analysts forecast that Guardian Pharmacy Services will post 1.19 EPS for the current year.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in GRDN. Jennison Associates LLC grew its stake in shares of Guardian Pharmacy Services by 609.5% in the first quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock worth $30,986,000 after acquiring an additional 706,823 shares during the last quarter. Sei Investments Co. increased its holdings in shares of Guardian Pharmacy Services by 40.5% during the first quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock valued at $13,489,000 after acquiring an additional 103,177 shares in the last quarter. Braun Stacey Associates Inc. purchased a new position in shares of Guardian Pharmacy Services in the 2nd quarter worth about $14,234,000. Dimensional Fund Advisors LP raised its position in shares of Guardian Pharmacy Services by 200.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock worth $7,855,000 after purchasing an additional 139,070 shares during the last quarter. Finally, Ranger Investment Management L.P. bought a new position in Guardian Pharmacy Services in the 2nd quarter worth about $7,263,000.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.
The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.
Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.
Featured Articles
- Five stocks we like better than Guardian Pharmacy Services
- 3 Tech Stocks Positioned for More Upside if the Sector’s Breakout Holds
- AutoZone Shifts Gears, On Track to Reverse Course and Price Recovery
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
